HippoFi, Inc. has entered the final phase of negotiations for definitive agreements as part of the confidential Letter of Intent with a highly respected leader in the industry. The Company plans to announce the intended long-term strategic relationship and asset acquisition soon, aiming to redefine the spinal biologic market. The strategic alliance will leverage the extensive expertise of both companies to create a breakthrough biomaterial that has already shown promise to be a game-changing solution for bone growth.